Todd is the President and CEO of WellAir. He brings 30 years of technology, medical device, and leadership experience. Prior to joining WellAir, Todd was the executive chairman of UV Innovators, which WellAir recently acquired. While at UV Innovators, Todd played an integral role in developing the world's first handheld instant UVC surface disinfection device, bringing a powerful and portable hospital-grade solution to all environments. In 2018, TIME Magazine named Todd one of the 50 Most Influential People in Health Care.
Before UV Innovators, Todd was the President and CEO of TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment.
Todd’s previous roles included Global President of Johnson & Johnson Cordis; where, he led a multi-billion-dollar business unit comprised of 3 distinct companies; Cardiology, Neurovascular, and Peripheral Vascular. Todd has also held various executive positions, including Liquidia Technologies' CEO, a nanotechnology-based healthcare company, in Research Triangle Park, North Carolina.
Significant portions of Todd's career have been spent focused on healthcare customers across the globe. He served 14 years in various management roles at Johnson & Johnson's Ethicon Endo-Surgery Division and Boston Scientific, where he rose to Vice President, Global Sales, and Marketing, Neurovascular Division.
Outside of WellAir, Todd serves on the Board of Directors of AdvaMed ACCEL. He also serves on the Kenan-Flagler Board of Visitors and the Educational Foundation for the University of North Carolina at Chapel Hill, where he is the immediate past Executive Chairman of the Board.